2010
DOI: 10.1016/j.jemermed.2008.02.033
|View full text |Cite
|
Sign up to set email alerts
|

Toxic Methemoglobinemia Due to Prilocaine Use

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
11
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 4 publications
(4 reference statements)
0
11
0
Order By: Relevance
“…Lethargy and stupor, and then dysrhythmias and seizures, usually appear at about 50%, and the lethal concentration is probably greater than 70%. (Kızılyıldız et al, 2008;Osterhoudt et al, 1995). The near-lethal level of methemoglobin observed in our patient may be attributed to age.…”
Section: Discussionmentioning
confidence: 45%
See 2 more Smart Citations
“…Lethargy and stupor, and then dysrhythmias and seizures, usually appear at about 50%, and the lethal concentration is probably greater than 70%. (Kızılyıldız et al, 2008;Osterhoudt et al, 1995). The near-lethal level of methemoglobin observed in our patient may be attributed to age.…”
Section: Discussionmentioning
confidence: 45%
“…MTH is characterized by elevation of haemoglobin levels with oxidized iron to ferric form (Fe 3+ ) which is inadequate for carrying oxygen (Gold and Bithoney, 2003;Kızılyıldız et al, 2008). MTH results most commonly from a toxic exposure.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Besides, presence of cyanosis and the cyanosis's not improving with oxygen therapy despite normal PaO 2 concentration in arterial blood gas in methaemoglobinaemia cases is an important finding. In some cases, O 2 saturation may decrease and may show inconsistency with PaO 2 concentration (15). Another diagnostic tool in methaemoglobinaemia is the CO-oximeter.…”
Section: Discussionmentioning
confidence: 99%
“…N-acetylcysteine and ascorbic acid have been proposed as alternative reductant therapies to methylene blue. Preclinical evidence for the role of ascorbic acid [21] has been validated by its successful use as primary therapy for methemoglobinemia [22,23]. Unlike methylene blue, its antioxidant effect is independent of NADPH [17].…”
Section: Discussionmentioning
confidence: 99%